Walking Ability and Limit of Stability in Children With Spastic Cerebral Palsy

Gait, Spastic Clinical Trial

Official title:

an Investigation of the Relationship Between Walking Ability and Limit of Stability in Children With Spastic Cerebral Palsy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05583929
• Other study ID #: GO-22/398
• Status: Recruiting
• Start date: November 29, 2022
• Est. completion date: June 1, 2024

Study information

• Verified date: November 2022
• Source: Mus Alparlan University
• Contact: Bayram Sirri, PT, MSc,
• Phone: +905362410774
• Email: bayramsirri[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Trunk control in children with spastic Cerebral Palsy (CP) is impaired. They have weaker trunk muscle strenght, and insufficient sitting/standing balance according to their developing peers. Since their weak trunk muscles and insufficient balance responses, they are not able to walk as functional similar to their peers. Additionaly limit of stability is worsen in children with CP. Investigation of the relationship between walking ability and limit of stability when seated position is important to understand which child is acceptable for training of walk. However we did not found any study to explain it. Therefore the aim of this study is to investigate walking ability and limit of stability in children with spastic CP, and to compare their developing peers.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: June 1, 2024
• Est. primary completion date: June 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Years to 15 Years

Eligibility

Inclusion Criteria:

• spastic serebral palsy, between the ages 6-15 years, between the I-IV. levels of GMFCS, be able to understand command given by physical therapist

Exclusion Criteria:

• undergone botulinum toxin A to upper and/or lower extremities, undergone any surgery to their extremities, be at the V. levels of GMFCS

Related Conditions & MeSH terms

• Cerebral Palsy
• Gait Disorders, Neurologic
• Gait, Spastic
• Muscle Spasticity

Intervention

Other:
• GAITRite gaitway system, Bertec Balance System
GAITRite gaitway system will use to assess gait parameters, Bertec Balance System will use to assess limit of stability

Locations

Country	Name	City	State
Turkey	Hacettepe University	Altindag	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Mus Alparlan University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gait parameters (stride length in cm, step width in cm, time in swing phase in second, time in stance phase in second)	Gait parameters will be assessed by GAITRite walking way system.	20 minutes
Primary	Limit of stability when sitting and standing position in cm	Limit of stability will be evaluated by BERTEC balance system.	20 minutes